Sign up & Download
Sign in

The Bipolar Association Case-Control Study (BACCS) and meta-analysis: No association with the 5,10-Methylenetetrahydrofolate reductase gene and bipolar disorder

by Sarah Cohen-Woods, Ian Craig, Darya Gaysina, Joanna Gray, Cerisse Gunasinghe, Nicholas John Craddock, Amanda Elkin, Lisa Jones, James Kennedy, Nicole King, Ania Korszun, Jo Knight, Michael John Owen, Sagar Parikh, John Strauss, Abram Sterne, Federica Tozzi, Julia Perry, Pierandrea Muglia, John Vincent, Peter McGuffin, Anne Farmer show all authors
American journal of medical genetics Part B Neuropsychiatric genetics the official publication of the International Society of Psychiatric Genetics (2010)

Abstract

Bipolar disorder (BD) is a complex genetic disease for which the underlying pathophysiology has yet to be fully explained. 5,10-Methylenetetrahydrofolate reductase (MTHFR) is a crucial enzyme in folate-mediated one-carbon metabolism and folate deficiency can be associated with psychiatric symptoms. A single base variant in MTHFR gene (C677T) results in the production of a mildly dysfunctional thermolabile enzyme and has recently been implicated in BD. We conducted an association study of this polymorphism in 897 patients with bipolar I or bipolar II disorder, and 1,687 healthy control subjects. We found no evidence for genotypic or allelic association in this sample. We also performed a meta-analysis of our own, and all published data, and report no evidence for association. Our findings suggest that the MTHFR C677T polymorphism is not involved in the genetic etiology of clinically significant BD.

Cite this document (BETA)

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Already have an account? Sign in

Readership Statistics

1 Reader on Mendeley
by Discipline
 
by Academic Status
 
100% Assistant Professor
by Country
 
100% Canada